College aantekeningen
Notities klinische biologische psychologie 2023 1MA VUB
97 keer bekeken
3 keer verkocht
Dit zijn notities van de lessen klinische biologische psychologie. Na elke les wordt het meest recente document upgeload. Veel succes!
[Meer zien]
Laatste update van het document: 1 jaar geleden
Voorbeeld 4 van de 93 pagina's
Geupload op
13 maart 2023
Bestand laatst geupdate op
26 mei 2023
Aantal pagina's
93
Geschreven in
2022/2023
Type
College aantekeningen
Docent(en)
Prof. deroost
Bevat
Alle colleges
Instelling
Vrije Universiteit Brussel (VUB)
Studie
Master In De Klinische Psychologie
Vak
Klinische Biologische Psychologie
Alle documenten voor dit vak (5)
€2,99
Ook beschikbaar in voordeelbundel v.a. €7,09
Toegevoegd
In winkelwagen
Op verlanglijstje
100% tevredenheidsgarantie
Direct beschikbaar na betaling
Zowel online als in PDF
Je zit nergens aan vast
Ook beschikbaar in voordeelbundel (1)
1MA 2de semester klinische psychologie VUB
1. College aantekeningen - Notities klinische biologische psychologie 2023 1ma vub
2. College aantekeningen - Notities hoc deontologie 1ma vub 2023
3. College aantekeningen - Notities hoc + wpo's pdka 2023 1ma vub
Meer zien
1
KLINISCHE BIOLOGISCHE PSYCHOLOGIE
INHOUD
Introductie ....................................................................................................................................................... 6
Onderwijsteam .................................................................................................................................................... 6
Doelstellingen + situering .................................................................................................................................... 6
Hoorcolleges ....................................................................................................................................................... 6
Evaluatie .............................................................................................................................................................. 6
WPO’s .................................................................................................................................................................. 7
Evaluatie .......................................................................................................................................................... 7
Voorbereiding ................................................................................................................................................. 7
Topics: subklinische populaties ....................................................................................................................... 8
Onderwerpen literatuuroverzicht ................................................................................................................... 8
Keuze onderwerp ............................................................................................................................................ 8
Opstellen onderzoeksvraag ............................................................................................................................. 9
Literatuuroverzicht .......................................................................................................................................... 9
Abstract ......................................................................................................................................................... 10
Presentatie .................................................................................................................................................... 10
Deadlines ....................................................................................................................................................... 10
Evaluatie ........................................................................................................................................................ 10
Neurobiologische perspectieven op autisme .................................................................................................. 11
Inhoud ............................................................................................................................................................... 11
Wat is autisme? ................................................................................................................................................. 11
DSM-V ........................................................................................................................................................... 11
Cognitieve theorieën ......................................................................................................................................... 11
Theory of Mind Baron-Cohen et al., 1990 ..................................................................................................... 11
Executief Dysfunctioneren Pennington & Ozonoff, 1996 ............................................................................. 12
Centrale Coherentie Frith, 1989 .................................................................................................................... 12
Neuro-ontwikkeling........................................................................................................................................... 12
Early Brain Overgrowth Theory (Courchesne et al., 2007) ............................................................................ 12
Over-pruning hypothesis (Thomas et al., 2016) ............................................................................................ 13
Excitatie-inhibitie Imbalans (Rubenstein & Merzenich, 2003) ...................................................................... 13
Primitive Brain Dysfunction Hypothesis (Jure, 2022) .................................................................................... 13
Belangrijke hersennetwerken ........................................................................................................................... 14
Saillantienetwerk .......................................................................................................................................... 14
Default Mode Network (DMN) ...................................................................................................................... 14
Central Executive Network (CEN) .................................................................................................................. 14
, 2
Samenspel! Hersenorkest ............................................................................................................................. 14
4e grote speler = Het Voorspellende Brein ................................................................................................... 15
Cerebellum: Functies .................................................................................................................................... 15
Anatomisch (structureel) Fatemi et al., 2012 ................................................................................................ 15
Neurobiologisch Fatemi et al., 2012 ............................................................................................................. 16
Connectiviteit ................................................................................................................................................ 16
Cerebello-cerebrale connecties .................................................................................................................... 16
Ontwikkeling ................................................................................................................................................. 16
Neurobiologische Theorieën (en het cerebellum) ............................................................................................. 17
Saillantie ........................................................................................................................................................ 17
Predictie ........................................................................................................................................................ 18
Integratief Kader ............................................................................................................................................... 20
Klinische Toepassingen?.................................................................................................................................... 20
Diagnostisch .................................................................................................................................................. 20
Interventies/ therapie Medicatie? .................................................................................................................... 22
Medicatie? .................................................................................................................................................... 22
Neurostimulatie ............................................................................................................................................ 22
Neurowetenschappelijke interventies .......................................................................................................... 23
Over het algemeen ........................................................................................................................................ 23
Psycho-educatie ............................................................................................................................................ 23
De ziekte van parkinson & gerelateerde stoornissen ...................................................................................... 24
Lesinhoud .......................................................................................................................................................... 24
Hersengebieden en functies ............................................................................................................................. 24
Frontale kwab: dysfuncties ........................................................................................................................... 24
Parietale kwab: dysfuncties .......................................................................................................................... 25
Temporale kwab: dysfuncties ....................................................................................................................... 25
Occipitale kwab: (dys)functies ...................................................................................................................... 25
Hersenstam: (dys)functies ............................................................................................................................ 25
Cerebellum: (dys)functies ............................................................................................................................. 26
Basale ganglia ................................................................................................................................................ 26
De ziekte van parkinson .................................................................................................................................... 27
Pathofysiologie .............................................................................................................................................. 27
Basale ganglia ................................................................................................................................................ 28
Basale ganglia: connectiviteit ........................................................................................................................ 28
Connectiviteit met andere structuren........................................................................................................... 29
Frontostriataal netwerk ................................................................................................................................ 29
Parkinson’s disease PD ...................................................................................................................................... 30
, 3
Klinische manifestaties .................................................................................................................................. 30
Motorische symptomen – rigiditeit .............................................................................................................. 30
Motorische symptomen - bradykinesie ........................................................................................................ 31
Motorische symptomen - Tremor ................................................................................................................. 31
Motorische symptomen - gangstoornissen .................................................................................................. 31
Motorische symptomen - Freezing of gait (FOG) .......................................................................................... 31
Klinische manifestaties .................................................................................................................................. 32
Niet-motorische sytmpomen – depressie ..................................................................................................... 32
Niet-motorische symtpomen - Apathie ........................................................................................................ 32
Niet motorische symptomen - impulsieve en compulsieve gedrgingen ....................................................... 33
Niet motorische symtpomen - executyieve functies .................................................................................... 33
Niet-motorische symptomen - cognitieve beperkingen ............................................................................... 34
Niet-motorische symptomen - dementie...................................................................................................... 34
Parkinsonisme (Parkinson +) ......................................................................................................................... 34
Multiple system atrophy (MSA) ........................................................................................................................ 35
Pathofysiologie .............................................................................................................................................. 35
Klinische Manifestaties ................................................................................................................................. 35
Fenotypes & Klinische Manifestaties ............................................................................................................ 36
Progressive supranuclear palsy ......................................................................................................................... 37
Pathofysiologie .............................................................................................................................................. 37
Fenotypes & Klinische Manifestaties ............................................................................................................ 37
Corticobasal degeneration (CBD) ...................................................................................................................... 38
Pathofysiologie .............................................................................................................................................. 38
Fenotypes & Klinische Manifestaties ............................................................................................................ 39
Lewy body dementia ......................................................................................................................................... 39
Pathofysiologie .............................................................................................................................................. 40
Klinische Manifestaties ................................................................................................................................. 40
Progressie ...................................................................................................................................................... 41
Rol van de psycholoog....................................................................................................................................... 41
Neuropsychologisch onderzoek bij bewegingsstoornissen ........................................................................... 41
Neuropsychologisch onderzoek .................................................................................................................... 42
Neuropsychologische principes bij de revalidatie van bewegingsstoornissen ............................................. 43
Schizofrenie.................................................................................................................................................... 44
Kenmerken ........................................................................................................................................................ 44
Drie types symptomen .................................................................................................................................. 44
Verloop en geslacht....................................................................................................................................... 44
Erfelijkheid ........................................................................................................................................................ 45
, 4
Verwanten ..................................................................................................................................................... 45
Mutaties ........................................................................................................................................................ 45
Leeftijd van de vader ..................................................................................................................................... 46
Omgevingsinvloeden ......................................................................................................................................... 46
Epidemiologie................................................................................................................................................ 46
Rol van stress ................................................................................................................................................ 48
Ontwikkeling ..................................................................................................................................................... 49
Brein .............................................................................................................................................................. 49
Dopaminehypothese ......................................................................................................................................... 51
Pathways ....................................................................................................................................................... 51
Aanwijzingen ................................................................................................................................................. 51
Mesolimbisch systeem: VTA ......................................................................................................................... 52
Tegenargumenten ......................................................................................................................................... 52
Hypofrontaliteit ............................................................................................................................................. 52
Glutamaathypothese .................................................................................................................................... 52
Motoriek en forward models ............................................................................................................................ 53
Corollary discharge........................................................................................................................................ 53
Evolutionaire paradox ....................................................................................................................................... 54
Creativiteit ..................................................................................................................................................... 54
N400 en openheid ......................................................................................................................................... 55
Verslaving ...................................................................................................................................................... 56
Inleiding ............................................................................................................................................................. 56
Definitie ......................................................................................................................................................... 56
Waarom? ....................................................................................................................................................... 56
Beloningssystemen ........................................................................................................................................... 58
Positieve bekrachtiging ................................................................................................................................. 60
Negatieve bekrachtiging ............................................................................................................................... 64
Executieve systemen ......................................................................................................................................... 65
Stress ................................................................................................................................................................. 66
Stressystemen ............................................................................................................................................... 66
Overzicht ........................................................................................................................................................... 68
Non-invasieve hersenstimulatie ..................................................................................................................... 69
Inleiding ............................................................................................................................................................. 69
Non-invasieve hersenstimulatie ........................................................................................................................ 70
Transcranial Magnetic Stimulation (tms) ...................................................................................................... 70
Transcranial Direct Current Stimulation (tDCS)............................................................................................. 71
Transcranial Alternating Current Stimulation (tACS) .................................................................................... 73